Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1286
-
Total 13F shares, excl. options
-
93M
-
Shares change
-
+959K
-
Total reported value, excl. options
-
$66.3B
-
Value change
-
+$312M
-
Put/Call ratio
-
0.91
-
Number of buys
-
547
-
Number of sells
-
-695
-
Price
-
$712.33
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2024
1,584 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2024.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,286 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93M shares
of 105M outstanding shares and own 88.59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.29M shares), BlackRock, Inc. (8.73M shares), FMR LLC (8.2M shares), JPMORGAN CHASE & CO (7.06M shares), STATE STREET CORP (4.83M shares), Capital International Investors (4.74M shares), Capital World Investors (2.78M shares), GEODE CAPITAL MANAGEMENT, LLC (2.43M shares), Dodge & Cox (2.32M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2.09M shares).
This table shows the top 1286 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.